Page last updated: 2024-09-04

8-chloroadenosine-3',5'-cyclic monophosphorothioate and n(6)-cyclopentyladenosine

8-chloroadenosine-3',5'-cyclic monophosphorothioate has been researched along with n(6)-cyclopentyladenosine in 1 studies

Compound Research Comparison

Studies
(8-chloroadenosine-3',5'-cyclic monophosphorothioate)
Trials
(8-chloroadenosine-3',5'-cyclic monophosphorothioate)
Recent Studies (post-2010)
(8-chloroadenosine-3',5'-cyclic monophosphorothioate)
Studies
(n(6)-cyclopentyladenosine)
Trials
(n(6)-cyclopentyladenosine)
Recent Studies (post-2010) (n(6)-cyclopentyladenosine)
1701605062

Protein Interaction Comparison

ProteinTaxonomy8-chloroadenosine-3',5'-cyclic monophosphorothioate (IC50)n(6)-cyclopentyladenosine (IC50)
Adenosine receptor A1Rattus norvegicus (Norway rat)0.2256
Adenosine receptor A2bRattus norvegicus (Norway rat)1.16
Adenosine receptor A1Homo sapiens (human)0.0027
Adenosine receptor A2aRattus norvegicus (Norway rat)1.16

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Christie, MJ; Hack, SP; Vaughan, CW1

Other Studies

1 other study(ies) available for 8-chloroadenosine-3',5'-cyclic monophosphorothioate and n(6)-cyclopentyladenosine

ArticleYear
Modulation of GABA release during morphine withdrawal in midbrain neurons in vitro.
    Neuropharmacology, 2003, Volume: 45, Issue:5

    Topics: Action Potentials; Adenosine; Affinity Labels; Animals; Colforsin; Cyclic AMP; Dipyridamole; Dose-Response Relationship, Drug; Drug Interactions; Enkephalins; Enzyme Inhibitors; gamma-Aminobutyric Acid; In Vitro Techniques; Isoquinolines; Male; Mesencephalon; Mice; Mice, Inbred C57BL; Morphine; Morphine Dependence; Naloxone; Narcotic Antagonists; Narcotics; Neural Inhibition; Neurons; Patch-Clamp Techniques; Periaqueductal Gray; Probenecid; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Substance Withdrawal Syndrome; Sulfonamides; Synaptic Transmission; Thioinosine; Time Factors; Uricosuric Agents; Vasodilator Agents; Xanthines

2003